Navigation Links
European biodiversity and ecosystem scientists merge and gear up for long-term research
Date:10/28/2008

Measures to tackle the human impact on biodiversity require long term research and collaboration between many countries working with common goals and frameworks. This emerged from a recent workshop organised by the European Science Foundation (ESF), which moved towards establishing an ESF Research Networking Programme (RNP) for ecosystem and biodiversity analysis on the back of existing initiatives.

Before finding conservation solutions, the big challenge is to understand how human activities and their possible consequences, such as climate and land use change, interact with ecosystems and alter biodiversity, according to Markus Fischer, convenor of the ESF workshop. The big first step will be to bring key researchers within Europe into a single "big tent" focusing on the whole field of biodiversity and associated ecosystem processes, from the molecular to the ecosystem level and across all groups of organisms. Until now, research into biodiversity and research into ecosystems have tended to be conducted separately even though the issues and underlying science are closely related. Thus, "the most important result of the workshop was the rapid consensus that the two previously separated fields - biodiversity and ecosystem research - should team up and integrate their results more intensively," said Fischer. "The best way to arrive at a better integration is by harmonising methodological protocols and agreeing on a sampling design for joint investigations on diversity and ecosystem processes." The workshop has laid the ground for such harmonisation.

The workshop identified the need to understand what features enable some species to benefit from changes and others to be driven out following various kinds of human activities, over both the short and long term."We can learn a lot about functional consequences of changes in biodiversity by comparing ecological traits of rare and endangered species with those from increasing or invasive species, or by comparing how these two groups of species respond to changes in the environment," said Fischer. "However, biodiversity research cannot be successful if it limits itself to the species level. Clearly, evolutionary biology must be integrated within innovative biodiversity research. Moreover, biological interactions need to be considered, including pollination, seed dispersal, predation, and decomposition, all constituting integral elements of ecosystem functioning."

All these objectives can only be met through a common approach linking suitable local projects on the ground across the whole of Europe. "It was generally agreed that functional biodiversity research requires a network of field sites distributed across Europe to cover different types of habitats, landscapes and land-uses," said Fischer. "Furthermore it was recognised that all facilities must allow the conduction of long-term research because of the non-linear, slow and often delayed response of ecological systems." In the long run, an integration of the network into currently emerging European research initiatives such as ANAAE and LIFEWATCH will allow the full potential for synergy to be realised.


'/>"/>

Contact: Markus Fischer
fischerm@rz.uni-potsdam.de
033-197-74884
European Science Foundation
Source:Eurekalert

Related biology news :

1. The MDS foundation supports vidazas recommendation for European approval
2. Vidaza receives positve opinion from European CHMP
3. European researchers harness unique properties of boron to develop new drugs and diagnostics
4. IronKey Opens New European Office
5. IOF calls on European citizens to stand tall and speak out for their bones
6. Major European program for the environment under the spotlight in Lille, France
7. Study helps pinpoint genetic variations in European Americans
8. European Science Foundation aims to strengthen regenerative medicine
9. European light research opens door for optical storage and computing
10. European membrane expertise to focus on new treatments for human diseases
11. ESFs European ice core project EPICA receives prestigious Descartes Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: